Kevin L. Otipoby (Preferred)
Kevin L. Otipoby
Chief Research Officer, Immunology, Seismic Therapeutic
Joined
May 2024
Names
Emails
****@seismictx.com (Confirmed)
Personal Links
Career & Education History
Chief Research Officer
Immunology, Seismic Therapeutic (seismictx.com)
2021 – Present
Vice President
Immunology, Pandion Therapeutics (pandiontx.com)
2017 – 2021
Principle Scientist
Immunology, AbbVie (abbvie.com)
2016 – 2017
Senior Scientist
Immunology, Biogen (biogen.com)
2011 – 2016
Postdoc
Rajewsky Lab, Harvard University (harvard.edu)
2001 – 2011
PhD student
Immunology, University of Washington, University of Washington (u.washington.edu)
1994 – 2000
Undergrad student
Arts and Sciences, Washington University, Saint Louis (wustl.edu)
1992 – 1994